Family Medicine · Templeton, CA
NPI
1770771511
Since 2007
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
699 S Main St
Templeton, CA, 93465
Phone (805) 434-1804
Groups this clinician bills Medicare through
Medicare paid, 2024
$287K
73,055 services
Medicare patients, 2024
277
Average age 76
Drug cost, 2024
$101K
2,177 prescriptions
Company payments, 2025
$124
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alexander F Castellanos was code J1071 (injection, testosterone cypionate, 1 mg), 69,400 times for 39 patients. In total Alexander F Castellanos billed 73,055 services in 88 codes, and Medicare paid $287K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-12-26.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 69,400 | 39 | $0.02 | $1,182 |
| 99214 Office E&M - Established | Office | 1,219 | 244 | $97.06 | $118K |
| 99215 Office E&M - Established | Office | 534 | 233 | $109.87 | $59K |
| 96372 Injection Administration | Office | 349 | 41 | $9.79 | $3,418 |
| 17003 Destruction Skin Lesion | Office | 247 | 16 | $4.88 | $1,206 |
| 93923 Duplex Scan - Extremity Arteries | Office | 126 | 123 | $102.54 | $13K |
| 94060 Pulmonary Function Testing | Office | 123 | 55 | $29.32 | $3,607 |
| 94640 Treatment - Miscellaneous | Office | 121 | 55 | $6.06 | $733 |
| 93000 Electrocardiogram | Office | 107 | 88 | $10.05 | $1,075 |
| 93015 Electrocardiogram | Office | 87 | 74 | $50.87 | $4,426 |
| 12031 Wound Repair - All Levels | Office | 65 | 49 | $201.94 | $13K |
| G0008 Administration of influenza virus vaccine | Office | 43 | 43 | $33.49 | $1,440 |
| 81002 Clinical Chemistry | Office | 43 | 30 | $3.41 | $147 |
| 90661 Vaccine Product | Office | 42 | 42 | $36.11 | $1,517 |
| 99205 Office E&M - New | Office | 40 | 40 | $123.80 | $4,952 |
By year: 2022 $336K for 66,303 services; 2023 $320K for 75,188 services; 2024 $287K for 73,055 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 43 | 30 | $3.41 | $147 |
Medicare prescription drug claims, 2024
In 2024, the drug Alexander F Castellanos prescribed most often to Medicare patients was Levothyroxine Sodium, with 306 prescriptions and refills. In total Alexander F Castellanos wrote 2,177 Medicare prescriptions that cost $101K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 306 | 915 | 85 | $4,365 |
| Losartan Potassium Generic | 197 | 582 | 54 | $2,277 |
| Pravastatin Sodium Generic | 153 | 456 | 45 | $2,178 |
| Verapamil Er Verapamil Hcl | 141 | 407 | 44 | $5,423 |
| Estradiol Generic | 117 | 318 | 32 | $3,428 |
| Amlodipine Besylate Generic | 84 | 239 | 27 | $770 |
| Prednisone Generic | 68 | 90 | 31 | $227 |
| Allopurinol Generic | 60 | 179 | 18 | $709 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 59 | 99 | 27 | $2,131 |
| Verapamil Sr Verapamil Hcl | 45 | 133 | 14 | $3,593 |
| Synthroid Levothyroxine Sodium | 42 | 126 | 12 | $3,725 |
| Metformin Hcl Generic | 41 | 119 | 12 | $423 |
| Doxycycline Hyclate Generic | 40 | 63 | 22 | $826 |
| Temazepam Generic | 39 | 41 | Under 11 | $286 |
| Atorvastatin Calcium Generic | 37 | 110 | 12 | $222 |
Brand drugs: - claims; generic drugs: 1,890 claims; opioid claims: 26.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alexander F Castellanos $124 ($124 in general payments such as food, travel and fees) from 1 company. The largest payer was Progenics Pharmaceuticals, Inc. with $124.
| Company | Payments | Amount |
|---|---|---|
| Progenics Pharmaceuticals, Inc. | 1 | $124 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.